BIRLAMCHI TIBBIY YORDAM TIZIMIDA TAKRORIY GEMORRAGIK INSULTNI OLDINI OLISHNING SHAXSIY STRATEGIYASINING SAMARADORLIGI
##article.subject##:
gemorragik insult, takroriy insult, profilaktika, birlamchi tibbiy yordam, shaxsiy tibbiyot, xavf stratifikatsiyasi##article.abstract##
Maqsad: Birlamchi tibbiy yordam sharoitida takroriy gemorragik insultni oldini olishning shaxsiy strategiyasining samaradorligini baholash. Material va usullar: Gemorragik insult o'tkazgan 240 nafar bemorning ishtirokida prospektiv nazorat ostidagi tadqiqot o'tkazildi. Asosiy guruh (n=120) ishlab chiqilgan xavf stratifikatsiyasi shkalasi asosida shaxsiy profilaktika oldi, nazorat guruhi (n=120) standart terapiya oldi. Kuzatuv davri 24 oyni tashkil etdi. Birlamchi yakuniy nuqta takroriy gemorragik insultlar chastotasi bo'ldi, ikkilamchi nuqtalar - o'lim darajasi, modifikatsiyalangan Rankin shkalasi (mRS) bo'yicha funktsional natijalar va hayot sifati. Natijalar: Asosiy guruhda takroriy gemorragik insultlar chastotasi 8,3% ni tashkil etdi, nazorat guruhida esa 18,3% (RR=0,45; 95% CI: 0,23-0,89; p=0,021). O'lim darajasi asosiy guruhda sezilarli darajada past bo'ldi (5,8% ga qarshi 14,2%; p=0,032). 24 oydan keyin funktsional mustaqillikka ega bemorlar ulushi (mRS 0-2) asosiy guruhda 67,5% ni tashkil etdi, nazorat guruhida esa 48,3% (p=0,003). Xulosa: Birlamchi tibbiy yordam tizimida takroriy gemorragik insultni oldini olishning shaxsiy strategiyasi takrorlanish chastotasini kamaytirish, o'lim darajasini pasaytirish va funktsional natijalarni yaxshilashda yuqori samaradorlikni ko'rsatadi.
Библиографические ссылки
Anderson CS, Huang Y, Lindley RI, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (INTERACT3): an open-label, blinded-endpoint, randomised controlled trial. Lancet. 2023;401(10383):1319-1328.
Biffi A, Kuramatsu JB, Leasure A, et al. Oral anticoagulant-related intracerebral hemorrhage. Stroke. 2021;52(1):233-243.
Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21(8):714-725.
Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820.
Hostettler IC, Schwarz G, Ambler G, et al. Intracerebral hemorrhage in the Swiss stroke registry (Swiss SOS): predictors of outcome and trends over time. Stroke. 2023;54(2):398-407.
Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2022;21(3):261-275.
Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022;93(4):431-441.
Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2021;20(11):931-940.
Wilson D, Ambler G, Banerjee G, et al. Statistical analysis plan for the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT2). Int J Stroke. 2023;18(2):234-241.
Zhang L, Chopp M, Zhang Y, et al. Diabetes mellitus and cerebral amyloid angiopathy: a review. J Neuroinflammation. 2022;19(1):248.
